Morin post-treatment surpassed calpeptin in ameliorating 3-NP-induced cortical neurotoxicity via modulation of glutamate/calpain axis, Kidins220, and BDNF/TrkB/AKT/CREB trajectory-Reference-Cited by-同舟云学术

Morin post-treatment surpassed calpeptin in ameliorating 3-NP-induced cortical neurotoxicity via modulation of glutamate/calpain axis, Kidins220, and BDNF/TrkB/AKT/CREB trajectory

Published:2023-03 Issue: Volume:116 Page:109771
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Mohamed Ola E.,Abdallah Dalaal M.^ORCID,Fayez Ahmed M.,Mohamed Reem A.,El-Abhar Hanan S.

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference76 articles.

1. Huntington’s disease clinical trials corner: June 2019;Rodrigues;Journal of Huntington’s Disease,2019

2. Tissue-specific proteolysis of huntingtin (htt) in human brain: Evidence of enhanced levels of N- and C-terminal htt fragments in Huntington’s disease striatum;Mende-Mueller;Journal of Neuroscience,2001

3. Brain imaging and cognitive dysfunctions in Huntington's disease;Montoya;J Psychiatry Neurosci,2006

4. Glutamate promotes proliferation of striatal neuronal progenitors by an NMDA receptor-mediated mechanism;Luk;Journal of Neuroscience,2003

5. Role of cerebral cortex in the neuropathology of Huntington’s disease;Estrada-Sánchez;Frontiers in Neural Circuits,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morin suppresses mTORc1/IRE-1α/JNK and IP3R-VDAC-1 pathways: Crucial mechanisms in apoptosis and mitophagy inhibition in experimental Huntington's disease, supported by in silico molecular docking simulations;Life Sciences;2024-02

2. Targeted Delivery of Engineered RVG-BDNF-Exosomes: A Novel Neurobiological Approach for Ameliorating Depression and Regulating Neurogenesis;Research;2024-01

3. Dimethyl fumarate abrogates striatal endoplasmic reticulum stress in experimentally induced late-stage Huntington’s disease: Focus on the IRE1α/JNK and PERK/CHOP trajectories;Frontiers in Pharmacology;2023-03-28